BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Meringer H, Shibolet O, Deutsch L. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm? World J Gastroenterol 2019; 25(29): 3929-3940 [PMID: 31413528 DOI: 10.3748/wjg.v25.i29.3929]
URL: https://www.wjgnet.com/1948-5182/full/v25/i29/3929.htm
Number Citing Articles
1
Anna Rossetto, Valli De Re, Agostino Steffan, Matteo Ravaioli, Gianmaria Miolo, Patrizia Leone, Vito Racanelli, Alessandro Uzzau, Umberto Baccarani, Matteo Cescon. Carcinogenesis and Metastasis in Liver: Cell Physiological BasisCancers 2019; 11(11): 1731 doi: 10.3390/cancers11111731
2
Elisabeth Digifico, Silvia Balinzo, Cristina Belgiovine. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor OnsetInternational Journal of Molecular Sciences 2021; 22(3): 1224 doi: 10.3390/ijms22031224
3
Jacopo Baglieri, Cuili Zhang, Shuang Liang, Xiao Liu, Takahiro Nishio, Sara B. Rosenthal, Debanjan Dhar, Hua Su, Min Cong, Jidong Jia, Mojgan Hosseini, Michael Karin, Tatiana Kisseleva, David A. Brenner. Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in MiceThe American Journal of Pathology 2021; 191(9): 1564 doi: 10.1016/j.ajpath.2021.05.019
4
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest ChinaWorld Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
5
Ahmet AKTAŞ, Engin ALTİNKAYA. DİREKT ETKİLİ ANTİVİRAL TEDAVİ ALAN KRONİK HEPATİT C HASTALARINDA ALFA FETOPROTEİN SONUÇLARININ DEĞERLENDİRİLMESİKırıkkale Üniversitesi Tıp Fakültesi Dergisi 2021; : 220 doi: 10.24938/kutfd.869839
6
Said A. Al-Busafi, Khalid AlNaamani. Liver Cancer in the Middle East2021; : 259 doi: 10.1007/978-3-030-78737-0_17
7
Vaishaali Natarajan, Camille R. Simoneau, Ann L. Erickson, Nathan L. Meyers, Jody L. Baron, Stewart Cooper, Todd C. McDevitt, Melanie Ott. Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture systemOpen Biology 2022; 12(3) doi: 10.1098/rsob.210320
8
Rossella Fasano, Mahdi Abdoli Shadbad, Oronzo Brunetti, Antonella Argentiero, Angela Calabrese, Patrizia Nardulli, Roberto Calbi, Behzad Baradaran, Nicola Silvestris. Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer TherapyLife 2021; 11(12): 1355 doi: 10.3390/life11121355
9
Lauren A. Beste, Pamela Green, Kristin Berry, Pamela Belperio, George N. Ioannou. Hepatitis C–Related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting AntiviralsJAMA 2020; 324(10): 1003 doi: 10.1001/jama.2020.10121
10
Mousumi Khatun, Ranjit Ray, Ratna B. Ray. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 103 doi: 10.1016/bs.acr.2020.10.003
11
Nermine Ehsan, Dina Sweed, Maha Elsabaawy. Evaluation of HCV-related liver fibrosis post-successful DAA therapyEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00129-0
12
Joshua P. Kronenfeld, Emily L. Ryon, David Goldberg, Rachel M. Lee, Adam Yopp, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Maria C. Russell, Alan S. Livingstone, Nipun B. Merchant, Neha Goel. Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative StudyAnnals of Surgical Oncology 2021; 28(4): 1929 doi: 10.1245/s10434-020-09156-4
13
David Rial-Crestelo, María Antonia Sepúlveda, Francisco Javier González-Gasca, Paloma Geijo-Martínez, Elisa Martínez-Alfaro, José Ramón Barberá, Miguel Yzusqui, Sonia Casallo, María García, Constanza Muñoz Hornero, Alfredo Espinosa-Gimeno, Miguel Torralba. Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?AIDS 2020; 34(3): 427 doi: 10.1097/QAD.0000000000002433
14
Hiromi Chikada, Kinuyo Ida, Yuji Nishikawa, Yutaka Inagaki, Akihide Kamiya. Liver-specific knockout of B cell lymphoma 6 suppresses progression of non-alcoholic steatohepatitis in miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66539-z
15
Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma TreatmentVaccines 2021; 9(5): 532 doi: 10.3390/vaccines9050532
16
Takashi Motomura, Sriram Amirneni, Ricardo Diaz-Aragon, Lanuza Faccioli, Michelle Malizio, Michael Coard, Zehra Kocas-Kilicarslan, Carla Frau, Nils Haep, Alina Ostrowska, Rodrigo Florentino, Alejandro Soto-Gutierrez. Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic TargetJournal of Personalized Medicine 2021; 11(7): 619 doi: 10.3390/jpm11070619
17
Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradicationWorld Journal of Gastroenterology 2022; 28(1): 140-153 doi: 10.3748/wjg.v28.i1.140
18
François-Loïc Cosset, Chloé Mialon, Bertrand Boson, Christelle Granier, Solène Denolly. HCV Interplay with Lipoproteins: Inside or Outside the Cells?Viruses 2020; 12(4): 434 doi: 10.3390/v12040434
19
Samira Ben Brahim, Daniel Hartmann, Michael W. Müller, Helmut Friess. Viszerale Operationen bei Patienten mit Leberzirrhose - was ist zu beachten?Gastro-News 2020; 7(5): 45 doi: 10.1007/s15036-020-1371-0